Walgreen Co. disclosed in its quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that the case captioned Himmel v. Wasson, et. al. is still pending in the Circuit Court of Lake County, Illinois.
On August 31,…
Walgreen Co. disclosed in its quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that the case captioned Himmel v. Wasson, et. al. is still pending in the Circuit Court of Lake County, Illinois.
On August 31,…
Mallinckrodt Inc., a subsidiary of Covidien Ltd., is one of four manufacturers of gadolinium-based contrast agents still involved in litigation alleging that administration of these agents causes development of a recently-identified disease, nephrogenic systemic fibrosis, in a small number of…
Biogen Idec Inc. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that it anticipates the trial on the Massachusetts Department of Revenue’s US$38.9 million tax assessment against its wholly owned subsidiary,…
Biogen Idec Inc. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that the European Commission, or the EC, published its final report on an inquiry in July 2009 in which it…
Biogen Idec Inc. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that on June 15, 2009, a panel issued its final decision in the arbitration filed by the Company against Genentech,Inc.…
Mediation on outstanding claims filed against Biogen Idec Inc. and its subsidiary Biogen Inc. (n/k/a Biogen Idec MA Inc.) over certain drugs for which Medicaid provides reimbursement (covered drugs) is still ongoing, The Company disclosed in its latest quarterly report…
Biogen Idec Inc. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that it is cooperating with the U.S. Department of Justice in its investigation of Genentech related to the promotion of…
Biogen Idec Inc. continues to defend itself in a lawsuit captioned United States of America ex rel. Paul P. McDermott v. Genentech Inc. and Biogen Idec Inc., filed on Jan. 6, 2006, in the U.S. District Court of the District…
An informal mediation on a lawsuit filed by the Attorney General of Arizona against Biogen Idec Inc. along with several other major pharmaceutical and biotechnology companies, in the Superior Court of the State of Arizona, is ongoing.
The complaint, transferred…